Doug Johnson is presently representing a major pharmacy retailer in a direct purchaser antitrust lawsuit against dozens of generic drug manufacturers. The drug manufacturers are alleged to have been engaged in a years-long conspiracy to allocate markets and customers among themselves, as well as raising and fixing prices of such generic drugs to anticompetitive levels. The complaint seeks damages in excess of $2.5 billion.
These cookies are essential for the website to function and cannot be switched off.
These cookies help us understand how visitors interact with the website by collecting information anonymously.
These cookies allow the website to remember choices you make to give you better functionality.
These cookies are used to track visitors across websites to display relevant advertising.